Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology
Reference37 articles.
1. WHO guidelines for the pharmacological and radiotherapeutic management of cancer pain in adults and adolescents. January 2019. https://www.who.int/ncds/management/palliative-care/cancer-pain-guidelines/en/. Accessed 7 Aug 2020.
2. Brar G, McNeel T, McGlynn K, Graubard B, Floudas CS, Morelli MP, Xie C, Greten TF, Altekruse S. Hepatocellular carcinoma (HCC) survival by etiology: a SEER-Medicare database analysis. J Clin Oncol. 2019;37:201. https://doi.org/10.1200/JCO.2019.37.4_suppl.201.
3. Target Oncology. Expert discusses sequencing TKI strategies in hepatocellular carcinoma. August 2019. https://www.targetedonc.com/view/expert-discusses-sequencing-tki-strategies-in-hepatocellular-carcinoma. Accessed 7 Aug 2020.
4. Cheng AL, Kang YK, Chen Z, Tsao CJ, Qin S, Kim JS, Luo R, Feng J, Ye S, Yang TS, Xu J, Sun Y, Liang H, Liu J, Wang J, Tak WY, Pan H, Burock K, Zou J, Voliotis D, Guan Z. Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial. Lancet Oncol. 2009;10:25–34. https://doi.org/10.1016/S1470-2045(08)70285-7.
5. Marmé F, Gomez-Roca C, Graudenz K, Huang F, Lettieri J, Peña C, Trnkova ZJ, Eucker J. Phase 1, open-label, dose-escalation study of sorafenib in combination with eribulin in patients with advanced, metastatic, or refractory solid tumors. Cancer Chemother Pharmacol. 2018;81:727–37. https://doi.org/10.1007/s00280-018-3540-9.
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献